ALNYLAM PHARMACEUTICALS INC (ALNY) Stock News
NASDAQ:ALNY - Nasdaq - US02043Q1076 - Common Stock - Currency: USD
ALNY Latest News, Press Relases and Analysis
Alnylam Issues 2024 Corporate Responsibility Report
$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
Smart Beta ETF report for XBI
$100 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
Snowflake Inc. (SNOW): Among the Best Growth Stocks to Buy and Hold for the Long Term
We recently compiled a list of the 12 Best Growth Stocks to Buy and Hold for the Long Term. In this article, we are going to take a look at where Snowflake Inc. (NYSE:SNOW) stands against the other growth stocks. What’s the Bull Case for US Equities? The market closed last week mostly lower, however, the […]
BioNTech SE (BNTX): Among the Best Growth Stocks to Buy and Hold for the Long Term
We recently compiled a list of the 12 Best Growth Stocks to Buy and Hold for the Long Term. In this article, we are going to take a look at where BioNTech SE (NASDAQ:BNTX) stands against the other growth stocks. What’s the Bull Case for US Equities? The market closed last week mostly lower, however, the […]
The inflation fight isn't over. Forecasters expect tariffs to show up in prices as soon as next month
Inflation could rise this summer as tariffs are reflected in the data, forecasters say. The US tariff rate is high even after the latest deal with China.
Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress
Why Sarepta Therapeutics, Inc. (SRPT) Nosedived on Wednesday
We recently published an article titled Why These 10 Firms Nosedived Today. In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands against the other stocks. The stock market bounced back from the previous day’s losses, with all major indices finishing higher as investors cheered the central bank’s decision to […]
Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference
Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Alnylam (ALNY) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
Alnylam (ALNY) delivered earnings and revenue surprises of 98.21% and 1.02%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: TGTX
Alnylam Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Period Progress
MiMedx (MDXG) Q1 Earnings Match Estimates
MiMedx (MDXG) delivered earnings and revenue surprises of 0% and 2.56%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MDXG
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations
The company sells a rival to Pfizer' heart treatment, Vyndaqel. Sales smashed expectations in its first quarter on the market.
Seeking Clues to Alnylam (ALNY) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Evaluate the expected performance of Alnylam (ALNY) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline
Axsome (AXSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: AXSM
Alnylam Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q1 Earnings Expected to Decline
Alnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: GSK
Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results
Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires?
We recently published a list of 10 Best Growth Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands against other best growth stocks to buy according to billionaires. Can the Stock Market Have a Big Rebound? The stock market has been […]
Is Zscaler, Inc. (ZS) the Best Growth Stock to Buy According to Billionaires?
We recently published a list of 10 Best Growth Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Zscaler, Inc. (NASDAQ:ZS) stands against other best growth stocks to buy according to billionaires. Can the Stock Market Have a Big Rebound? The stock market has been on […]
Why Eli Lilly and Company (LLY) Is the Best Medical Stock to Buy According to Billionaires
We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best medical stocks to buy according to billionaires. Why are Healthcare Stocks Under Pressure? Some experts view medical, healthcare, and […]
I'm in my 30s and just got married. I want to sell my home, move in with my spouse. Is selling the best move?
There are many things to consider when selling a home. Here's how to navigate them.
Is AppLovin Corporation (APP) the Best Long Term Growth Stock to Buy According to Billionaires?
We recently published a list of 10 Best Long Term Growth Stocks to Buy According to Billionaires. In this article, we are going to take a look at where AppLovin Corporation (NASDAQ:APP) stands against other best long term growth stocks to buy according to billionaires. As per Barclays, the US administration announced numerous executive orders with […]
Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires?
We recently published a list of 10 Best Long Term Growth Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands against other best long term growth stocks to buy according to billionaires. As per Barclays, the US administration announced numerous executive […]
